
Cardiomatics
Founded Year
2017Stage
Seed VC | AliveTotal Raised
$3.2MLast Raised
$2.2M | 4 yrs agoMosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
-97 points in the past 30 days
About Cardiomatics
Cardiomatics operates in the healthcare technology sector, focusing on ECG analysis. The company provides automated long-term ECG interpretation and arrhythmia diagnostics using a cloud-based platform for ECG signal analysis and reporting. Cardiomatics serves cardiac clinics and service providers. It was founded in 2017 and is based in Krakow, Poland.
Loading...
Cardiomatics's Product Videos
Cardiomatics's Products & Differentiators
Cardiomatics
Cardiomatics is web app which offers cutting-edge, cloud AI-based digital analyses of data from Holter ECGs. Our medical-grade system, based on accurate algorithms, ensures high-quality and trusted outcomes. Healthcare providers can now quickly receive an easy-to-read report and benefit from smarter diagnoses and better workflows.
Loading...
Expert Collections containing Cardiomatics
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Cardiomatics is included in 2 Expert Collections, including Artificial Intelligence (AI).
Artificial Intelligence (AI)
16,409 items
Companies developing artificial intelligence solutions, including cross-industry applications, industry-specific products, and AI infrastructure solutions.
Digital Health
12,122 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Latest Cardiomatics News
Oct 31, 2024
July 26, 2024 Your morning summary of digital health news, information and events to know about if you want to be “in the know”. 👇 News ♥️ AI diagnostics company Cardiomatics and UC and Cornell University have published a study demonstrating AI’s potential to expand heart rhythm monitoring in sub-Saharan Africa. Using AI to analyze ECG data remotely, researchers showed how AI-driven diagnostics could help bridge healthcare gaps in regions with limited infrastructure. The findings were published in JACC: Clinical Electrophysiology and highlight AI’s role in supporting heart health services for underserved populations. 💰 Eight companies have been awarded grants of up to £5,000 to develop new healthcare solutions as part of Anglia Ruskin University’s Arise Innovation Hubs’ ABOVE program. Funded by Essex County Council, ABOVE grants support Essex-based SMEs and nonprofits working on medtech projects, including virtual reality (VR) therapy, AI-driven diagnostics and NHS demand management tools. Recipients include Aerial Icon, Elixir AI and C-Prio Ltd. 🫁 AI technology designed to help catch lung cancer earlier will be rolled out across the NHS in the North East and North Cumbria after a successful bid for national funding. The Annalise.ai tool will be added to X-ray kits at Imaging Network member hospitals, following a successful bid for funding supported by the Provider Collaborative. The bid was also supported by the Northern Cancer Alliance with funding awarded through NHS England’s AI Diagnostic Fund, which provides £21 million to 12 imaging networks covering 65 NHS trusts. 🚀 Scottish tech company Novosound has unveiled what it says is the world’s first ultrasonic blood pressure monitor, a wearable device designed to measure blood pressure via smartwatches or rings with the accuracy of traditional monitors. Built on its Slanj software platform, the technology has been successfully tested in real-world settings and recently presented at the IEEE Ultrasonics Symposium. Supported by a £2 million funding round, Novosound plans to showcase its technology at CES 2025. 🤖 The Royal Free Hospital has introduced robotic surgery for liver, bile duct and pancreatic procedures, enabling more precise, minimally invasive operations. The Da Vinci robot has been in use at the Royal Free Hospital since 2016 and has primarily been used to treat patients with kidney cancer. The robot offers surgeons magnified 3D views and greater precision, and is expected to reduce infection risks and speed up recovery times. ❓Did you know? The latest Cancer Registration Statistics show the NHS diagnosed over 11,000 more cancers in 2022, reaching a new record high level, with almost 950 people a day getting a diagnosis in England. More cancers were diagnosed in 2022, with 346,217 new diagnoses, an average of 948 a day, compared to 329,664 in 2021, an increase of 5%. The data also shows that mortality rates from cancer are continuing to reduce – in men the rate fell from 345 deaths per 100,000 people in 2011 to 299 deaths per 100,000 people in 2022. Similarly, for women, the rate fell from 237 deaths per 100,000 people in 2011 to 212 deaths per 100,000 people in 2022. 📖 What we’re reading NHS Confederation’s response to the 2024 Autumn Budget , published on 30 October, offers a detailed breakdown of the Chancellor’s £22 billion health and social care funding boost. Authored by Jonathan Barron and Skeena Williamson, the report notes that, while NHS England’s budget increase of 4.7% this year and 3.3% next year are front-loaded to address pay deals and existing deficits, it leaves limited room for major service improvements. They also highlight the government’s shift to a two-phase Spending Review, with the next phase in spring 2025. NHS Confederation argues that for the NHS to truly meet productivity and service goals, the government needs to consider more comprehensive capital reform and establish clearer fiscal protections for preventative spending, which they say is vital for sustainable growth in health and care services. 🚨Upcoming events
Cardiomatics Frequently Asked Questions (FAQ)
When was Cardiomatics founded?
Cardiomatics was founded in 2017.
Where is Cardiomatics's headquarters?
Cardiomatics's headquarters is located at ul. Wojciecha Weiss 7, lok, Krakow.
What is Cardiomatics's latest funding round?
Cardiomatics's latest funding round is Seed VC.
How much did Cardiomatics raise?
Cardiomatics raised a total of $3.2M.
Who are the investors of Cardiomatics?
Investors of Cardiomatics include Poland National Research and Development Center, Nova Capital Management, Innovation Nest, Kaya VC, Nina Capital and 4 more.
Who are Cardiomatics's competitors?
Competitors of Cardiomatics include CardioAI and 6 more.
What products does Cardiomatics offer?
Cardiomatics's products include Cardiomatics.
Who are Cardiomatics's customers?
Customers of Cardiomatics include CardioParc, https://magdalena.hr/, DelhiCardio, American Heart of Poland and Alexandru Mischie.
Loading...
Compare Cardiomatics to Competitors

Powerful Medical focuses on artificial intelligence (AI) driven healthcare solutions within the medical diagnostics sector. The company provides the PMcardio platform, which uses artificial intelligence to interpret 12-lead electrocardiograms (ECGs) for the diagnosis of cardiovascular diseases. PMcardio's technology aims to assist healthcare professionals by improving diagnostic capabilities and facilitating care coordination. It was founded in 2017 and is based in Bratislava, Slovakia (Slovak Republic).

XOresearch focuses on AI-assisted cardiac diagnostics within the healthcare sector. The company has a cloud-based platform for ECG analytics and remote cardiac monitoring solutions using single-use ECG biosensors. XOresearch serves healthcare providers with capabilities for heart disease detection and cardiac monitoring. It was founded in 2015 and is based in Riga, Latvia.

Idoven is a health technology company that focuses on detection and medicine in the cardiovascular domain. The company offers an artificial intelligence (AI)-powered platform that improves the speed, consistency, and accuracy of electrocardiogram (ECG) interpretation and works with existing ECG devices to support clinician decision-making and disease management. It was founded in 2018 and is based in Madrid, Spain.
CardioAI specializes in automatic annotation and interpretation of electrocardiogram (ECG) records across various lead combinations within the healthcare sector. The company provides access to its solutions for ECG technicians and physicians to prepare and analyze ECG reports, focusing on cardiac health monitoring. CardioAI serves healthcare providers with an emphasis on heart health diagnostics. It was founded in 2015 and is based in Riga, Latvia.

Anumana is an AI-driven health technology company focused on transforming cardiac care through advanced analysis of electrical signals from the heart. The company offers AI solutions that enable earlier diagnosis of cardiovascular diseases and improve clinical decision-making in electrophysiology. Anumana's products are designed for integration into clinical workflows, for healthcare providers in early disease detection and intervention and enhancing patient safety and outcomes. It was founded in 2021 and is based in Cambridge, Massachusetts.
SIMPLEX QUANTUM (SQ) is a medical technology company that develops diagnostic processes within the healthcare sector using artificial intelligence (AI). The company creates tools for the identification of cardiovascular diseases, utilizing machine learning technologies to analyze electrocardiogram (ECG) data for heart failure detection. It works with academic institutions such as the University of Tokyo Hospital to support its research and application of AI in healthcare. It was founded in 2014 and is based in Tokyo, Japan.
Loading...